Impact of Cigar Flavor in Dual Users
Impact of Cigar Flavor on Tobacco Use Behaviors and Addiction in Dual Users
2 other identifiers
interventional
89
1 country
1
Brief Summary
The purpose of this study is to understand addiction to filtered cigars (FCs) compared to cigarettes in young adults, ages 21-34, who smoke both cigarettes and cigars. We are also looking to see if flavors, such as fruit or menthol, make FCs more addictive and if there are differences between men and women. Participants will receive 2 weeks supply of FCs, one week flavored and another week unflavored. You will be randomized (like flipping a coin) to which type of FC you will receive first. The study will:
- take about 3-4 hours of your time per week over 3-5 weeks.
- be conducted remotely by phone, video call, email, and mail.
- require a smart phone to answer 5 quick surveys a day
- you will need to answer 4 weekly surveys
- take part in a weekly video or phone call with research staff
- supply three saliva samples to be later tested for nicotine and other toxicants
- and use a device to measure your carbon monoxide levels four times a day. You will be compensated for your time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 24, 2020
CompletedFirst Submitted
Initial submission to the registry
July 14, 2020
CompletedFirst Posted
Study publicly available on registry
July 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedOctober 7, 2025
October 1, 2025
4.4 years
July 14, 2020
October 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in demand elasticity for preferred flavored filtered cigars
It is measured by the Cigarette Purchase Task, which will be adapted to assess these products. It is the hypothetical consumption of flavored cigars at increasing prices.
3-5 weeks
Change in demand elasticity for preferred unflavored filtered cigars
It is measured by the Cigarette Purchase Task, which will be adapted to assess these products. It is the hypothetical consumption of unflavored cigars at increasing prices.
3-5 weeks
Change in cross price elasticity for filtered cigars and cigarettes
It is measured by the Cross-Price Purchase Task. It is the hypothetical consumption of flavored and unflavored filtered cigars as cigarette prices increase.
3-5 weeks
Secondary Outcomes (1)
Change in exhaled breath carbon monoxide (CO) level
3-5 weeks
Other Outcomes (2)
Change in saliva cotinine levels
3-5 weeks
Change in number of flavored cigars, unflavored cigars, and cigarettes smoked per day
3-5 weeks
Study Arms (2)
Flavored Filtered Cigars
EXPERIMENTALHalf of the group will be randomized to start with flavored filtered cigars (FCs) at the second visit and cross over to unflavored FCs at the third visit. FCs will be Cheyenne filtered cigars.
Unflavored Filtered Cigars
EXPERIMENTALHalf of the group will be randomized to start with unflavored FCs at the second visit and cross over to flavored FCs at the third visit. FCs will be Cheyenne filtered cigars.
Interventions
Flavored and unflavored Cheyenne filtered cigars that are currently available in the marketplace for purchase
Flavored and unflavored Cheyenne filtered cigars that are currently available in the marketplace for purchase
Eligibility Criteria
You may qualify if:
- Current regular dual uses of filtered cigars and cigarillos (FCs) and cigarettes defined as; (a) report smoking cigarettes at least weekly in the past 30 days, (b) report smoking unaltered FC (without marijuana) at least weekly in the past 30 days; and (c)report cigarette and cigar use at their current rate (or more frequently) for ≥ 3 months.
- Able to read, speak, and understand English
- Age 21-34 years
- Stable residence (does not intend to move during the study period)
- Not intending to quit smoking during the study period
- Has a smart phone with a data plan (this study is being done remotely)
- Saliva cotinine level \>30 ng/mL
You may not qualify if:
- Self-reported current pregnancy, currently trying to become pregnant, or breast-feeding
- Current use of nicotine replacement products or cessation products (e.g., bupropion) or plans to use in the next 3 weeks for the purposes of cessation.
- Diagnosed with or being treated for COPD, emphysema, and/or uncontrolled asthma as determined by research screening.
- Currently taking anti-hypertensive medications
- Currently has pneumonia, bronchitis, or COVID symptoms that has not yet resolved, or was hospitalized or visited the ER in the past 4 weeks for a respiratory-related illness that has not yet resolved (can be re-screened once resolved)
- Resident of Alaska, Hawaii, or Massachusetts
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UConn Healthlead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
UConn Health
Farmington, Connecticut, 06030, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erin Mead-Morse, PhD,MHS
UConn Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 14, 2020
First Posted
July 27, 2020
Study Start
June 24, 2020
Primary Completion
November 30, 2024
Study Completion
November 30, 2024
Last Updated
October 7, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- In the final year of the Award after the dataset is finalized we will prepare a file in Excel and Stata that contains all study variables intended for use in presentations and publications.
A verified database will be available once the main findings from the final dataset have been reported and accepted for publication. Information that does result from our analysis of the saliva samples will be available after publication of the findings. De-identified dataset will contain the data merged from all study visits. We will include with the data file proper documentation of all data (including definitions of variables and derived variables, frequencies, details about codes, etc.), and procedures used to collect the data, to ensure others can use the dataset and to prevent misuse, misinterpretation, and/or confusion. The database intended for public distribution will be free of identifiers that would permit linkages to individual research participants and variables that could lead to deductive disclosure of the identity of individual subjects.